Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1995
03/30/1995WO1995008622A1 Recombinant infectious laryngotracheitis virus and uses thereof
03/30/1995WO1995008576A1 Monoclonal antibodies against leukocyte-specific g-protein-coupled receptors
03/30/1995WO1995008574A1 Displacement chromatography process and purified hemoglobin product
03/30/1995WO1995008573A1 Peptide having antithrombotic activity and process for producing the same
03/30/1995WO1995008572A1 Interaction of t-cell receptors and antigen in autoimmune disease
03/30/1995WO1995008571A1 Porcine somatotropin having enhanced stability; process for producing
03/30/1995WO1995008570A1 Chimeric proteins which block complement activation
03/30/1995WO1995008569A1 NOVEL PROTEIN sp38 AND CONTRACEPTIVE VACCINE
03/30/1995WO1995008568A1 VIRULENCE ASSOCIATED PROTEINS IN BORRELIA BURGDORFERI $i(Bb)
03/30/1995WO1995008567A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
03/30/1995WO1995008566A1 Novel peptide
03/30/1995WO1995008564A1 PEPTIDE DERIVATIVES OF α-MSH AND THEIR APPLICATION
03/30/1995WO1995008560A1 Novel peptides useful for inhibiting binding of lipopolysaccharides (lps) by lipopolysaccharide binding protein (lbp)
03/30/1995WO1995008554A1 Nf-at polypeptides and polynucleotides
03/30/1995WO1995008347A1 Methods and products for controlling immune responses in mammals
03/30/1995WO1995008344A1 Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic
03/30/1995WO1995008343A1 Modified truncated complement system regulators
03/30/1995WO1995008338A1 Method for the treatment or prevention of eczema/dermatitis
03/30/1995WO1995008336A1 Graves' ophthalmopathy associated antibodies, graves' ophthalmopathy orbital antigen, and methods of use thereof
03/30/1995WO1995005452A3 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
03/30/1995WO1995002694A3 Materials and methods for the control of calliphoridae pests
03/30/1995WO1995000852A3 A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130
03/30/1995WO1994029467A3 Methods and compositions for modulating lipid content of plant tissues
03/30/1995WO1994028153A3 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
03/30/1995WO1994024279A3 Agents for the prevention and treatment of huntington's disease and other neurological disorders
03/30/1995CA2172610A1 Chimeric proteins which block complement activation
03/30/1995CA2172512A1 Interaction of t-cell receptors and antigen in autoimmune disease
03/30/1995CA2172491A1 Method for the treatment or prevention of eczema/dermatitis
03/30/1995CA2172490A1 Receptor recognition factors, protein sequences and methods of use thereof
03/30/1995CA2172387A1 Recombinant infectious laryngotracheitis virus and uses thereof
03/30/1995CA2172385A1 Nucleic acids encoding merosin, merosin fragments and uses thereof
03/30/1995CA2172287A1 Nf-at polypeptides and polynucleotides
03/30/1995CA2172158A1 Treatment of immunologic and hematologic disorders with igfbp alone or complexed with igf
03/30/1995CA2172073A1 Expression of viral decoy proteins under the control of a locus control region and uses thereof
03/30/1995CA2171206A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds
03/30/1995CA2170521A1 Immunoreactive antigens of hepatitis e virus
03/30/1995CA2149783A1 Novel peptides
03/29/1995EP0645454A2 Chimeric somatostatin containing protein and coding DNA, immunogenic compositions and method for increasing farm animal productivity
03/29/1995EP0645452A1 Human interferon-beta 2A and interfeon-beta 2B, vectors containing genes coding for said interferons, cell lines producing same and use of said interferons as pharmaceuticals
03/29/1995EP0645451A1 Heparin binding site structural analogues of fibroblast growth factors
03/29/1995EP0645450A1 Human calcitonin precursor polyprotein structural gene
03/29/1995EP0645399A2 Ribosome inactivating proteins (RIB), their method of production and medical preparation containing RIP
03/29/1995EP0645136A2 Physiologically active substance-prolonged releasing-type pharmaceutical preparation
03/29/1995EP0644946A1 Vector particles resistant to inactivation by human serum
03/29/1995EP0644944A1 Adeno-associated virus with inverted terminal repeat sequences as promoter
03/29/1995EP0644938A1 PRODUCTION OF STREPTAVIDIN FROM $i(BACILLUS SUBTILIS)
03/29/1995EP0644937A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression
03/29/1995EP0644936A1 Chimeric receptor polypeptides, human h13 proteins and uses thereof
03/29/1995EP0644935A1 DNA SEQUENCES ENCODING THE HUMAN A1, A2a and A2b ADENOSINE RECEPTORS
03/29/1995EP0644934A1 SEQUENCE OF HUMAN DOPAMINE TRANSPORTER cDNA
03/29/1995EP0644933A1 Constitutive and inducible epidermal vector systems
03/29/1995EP0644932A1 Purified forms of dnase
03/29/1995EP0644931A1 Recombinant herpesvirus of turkeys and uses thereof
03/29/1995EP0644930A1 Monoclonal antibody against the extra-villous trophoblast
03/29/1995EP0644900A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
03/29/1995EP0644899A1 Production of recombinant human lactoferrin
03/29/1995EP0644898A1 Filamentous fungus proteins for binding and transporting lipids, preparation method therefor and use thereof
03/29/1995EP0644897A1 New peptides and proteins, process for their preparation and their use as cholesterol acceptors
03/29/1995EP0644895A1 Active component of parathyroid hypertensive factor
03/29/1995EP0644892A1 Inhibitors of angiotensin i chymase(s) including human heart chymase
03/29/1995EP0644889A1 COMPOSITIONS AND METHODS FOR MODULATING $g(b)-AMYLOID
03/29/1995EP0644884A1 Novel tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
03/29/1995EP0644778A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING.
03/29/1995EP0644774A1 Improved production of reproductive hormones
03/29/1995EP0644772A1 Opioid peptides
03/29/1995EP0644770A1 Stabilized somatotropin for parenteral administration
03/29/1995EP0644769A1 Biologically active peptides having n-terminal substitutions
03/29/1995EP0644768A1 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
03/29/1995EP0563144B1 Diagnosis for porcine malignant hyperthermia
03/29/1995EP0500602B1 Agent for neutralising the procoagulant activity associated with tumor cells
03/29/1995EP0436005B1 Labeled polypeptide derivatives
03/29/1995EP0374162B1 Balanced constitutive inducible transcription system
03/29/1995EP0332667B1 Vector for integration site independent gene expression in mammalian host cells
03/29/1995CN1100757A Novel plasmid for production of CRM protein and diphtheria toxin
03/28/1995US5401836 Polynucleotides with sequences for genetic engineering
03/28/1995US5401835 Human erythroid p55 nucleic acids
03/28/1995US5401832 Brain derived and recombinant acidic fibroblast growth factor
03/28/1995US5401831 Monoclonal antibodies for differentiating pathogenic and nonpathogenic E. histolytica
03/28/1995US5401830 Polypeptide for binding insulin
03/28/1995US5401829 Biologically active molecules
03/28/1995US5401828 Mutant genes present in malignant tumors, detection, tumor specific antibodies for treatment
03/28/1995US5401766 Aminoacid derivatives, a process for their preparation, agents containing these compounds, and the use thereof
03/28/1995US5401721 Antiulcer agents and antisecretory agents
03/28/1995US5401658 Vectors and methods for making such vectors and for expressing cloned genes
03/28/1995US5401656 Screening for Rocky Mountain spotted fever and ehrlichiosis
03/28/1995US5401652 Nucleic acid sequence encoding apamin receptor protein
03/28/1995US5401651 DNA encoding ENA-78, a neutrophil activating factor
03/28/1995US5401650 Cloning and expression of biologically active α-galactosidase A
03/28/1995US5401643 Method of preparing an active human neutrophil chemotactic factor polypeptide
03/28/1995US5401642 Vectors and methods for making such vectors and for expressing cloned genes
03/28/1995US5401638 Detection and quantification of neu related proteins in the biological fluids of humans
03/28/1995US5401635 Nucleic acids encoding human prohibitin mutants and detection thereof
03/28/1995US5401634 Stable biologically active fluorochemical emulsions
03/28/1995US5401629 Assay methods and compositions useful for measuring the transduction of an intracellular signal
03/28/1995US5401628 Polypeptides derived from the human immunodeficiency virus endonuclease protein
03/28/1995US5401627 Warts, cancer
03/28/1995US5401626 Diagnosis
03/28/1995CA2108401A1 Receptor induced by lymphocyte activation in imflammatory response
03/28/1995CA1334944C Signal peptide, dna sequences coding for the latter, expression vectors carrying one of these sequences, gram-negative bacteria transformed by these vectors, and process for the periplasmic production of a polypeptide
03/28/1995CA1334943C Leader sequence for the production of recombinant proteins
1 ... 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 2621 2622 2623 2624 2625 2626 2627 ... 2916